New Frontiers in the Role of Locoregional Therapies in Breast Cancer: Proceedings from the Society of Interventional Radiology Foundation Research Consensus Panel

Emerging evidence regarding the effectiveness of locoregional therapies (LRTs) for breast cancer has prompted investigation of the potential role of interventional radiology (IR) in the care continuum of patients with breast cancer. The Society of Interventional Radiology Foundation invited 7 key op...

Full description

Saved in:
Bibliographic Details
Published inJournal of vascular and interventional radiology Vol. 34; no. 10; pp. 1835 - 1842
Main Authors Daye, Dania, Panagides, John, Norton, Larry, Ahmed, Muneeb, Fukuma, Eisuke, Ward, Robert C., Gomez, Daniel, Kokabi, Nima, Vogl, Thomas, Abi-Jaoudeh, Nadine, Deipolyi, Amy
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.10.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Emerging evidence regarding the effectiveness of locoregional therapies (LRTs) for breast cancer has prompted investigation of the potential role of interventional radiology (IR) in the care continuum of patients with breast cancer. The Society of Interventional Radiology Foundation invited 7 key opinion leaders to develop research priorities to delineate the role of LRTs in both primary and metastatic breast cancer. The objectives of the research consensus panel were to identify knowledge gaps and opportunities pertaining to the treatment of primary and metastatic breast cancer, establish priorities for future breast cancer LRT clinical trials, and highlight lead technologies that will improve breast cancer outcomes either alone or in combination with other therapies. Potential research focus areas were proposed by individual panel members and ranked by all participants according to each focus area’s overall impact. The results of this research consensus panel present the current priorities for the IR research community related to the treatment of breast cancer to investigate the clinical impact of minimally invasive therapies in the current breast cancer treatment paradigm. [Display omitted]
Bibliography:SourceType-Scholarly Journals-1
ObjectType-News-1
ObjectType-Feature-4
ObjectType-Conference-2
content type line 23
ObjectType-Article-3
ISSN:1051-0443
1535-7732
1535-7732
DOI:10.1016/j.jvir.2023.06.037